BALTIMORE CITY – MD: Mayor Scott’s Statement on Back River and Patapsco Wastewater Treatment Plants

BALTIMORE CITY – MD: Mayor Scott’s Statement on Back River and Patapsco Wastewater Treatment Plants
0Comments

Baltimore City – MD issued the following announcement on Mar. 28.

Mayor Brandon M. Scott released the following statement in response to action taken by the Maryland Department of the Environment.

“The Back River and Patapsco Wastewater Treatment Plants have had issues that long predate my administration. We are committed to working with the Maryland Department of the Environment (MDE) and the Maryland Environmental Service (MES) to get both of these facilities into compliance. This will not be an overnight fix but we must work collaboratively and combine our resources in order to ensure clean and healthy communities not just for our residents, but also for the wildlife that calls the Chesapeake Bay home.”

Mayor Brandon M. Scott

Original source can be found  here.

Featured image

Source: Baltimore City – MD



Related

James “Jim” Sigg FDA%27s Deputy Commissioner for Operations and Chief Operating Officer - Official Website

FDA inspects Bora Pharmaceuticals Injectables, Inc. facility in Baltimore on July 25, 2024

On July 25, 2024, the Food and Drug Administration conducted an inspection of Bora Pharmaceuticals Injectables, Inc. in Baltimore, focusing on blood and blood products, according to the FDA’s website.

Benjamin D. Moncarz Chief Financial Officer - FDA - Official Website

Yia Yia’s Bakery, Inc. in Baltimore inspected by FDA on Feb. 23, 2024

On February 23, 2024, the Food and Drug Administration (FDA) conducted an inspection of Yia Yia’s Bakery, Inc. in Baltimore to assess foodborne biological hazards, according to information available on the FDA’s website.

Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration - Official Website

FDA inspects BC3 Technologies in Baltimore on Nov. 26, 2024

On November 26, 2024, BC3 Technologies in Baltimore underwent an FDA inspection focused on device compliance and post-market assurance, as detailed on the FDA’s website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Baltimore City Wire.